Fast Five Quiz: Acetaminophen

Mary L. Windle, PharmD


July 22, 2021

Lixisenatide is a once-daily injectable GLP-1 receptor agonist used in patients with type 2 diabetes. GLP-1 agonists delay gastric emptying, which may affect the absorption of concomitantly administered medications. Lixisenatide can decrease the level and effect of acetaminophen; modification to therapy or close monitoring is recommended. Serious interactions with acetaminophen may occur in patients taking lonafarnib, pexidartinib, or pretomanid.

Review drug interactions with acetaminophen.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.